ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Jasper Therapeutics
Jasper is a biotechnology company dedicated to developing therapies for chronic and life-threatening diseases, aiming to make safer and potentially curative treatments accessible to more patients. The company values high-performing professionals, academic partnerships, and investment in innovation.
Jasper Therapeutics is a biotechnology company focused on targeting mast cells to treat chronic mast cell diseases. Its lead program Briquilimab is a targeted anti-KIT monoclonal antibody designed to deplete mast cells for the treatment of chronic immunological and inflammatory diseases, with clinical studies in chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and allergic asthma. The company collaborates with academic centers and biopharmaceutical partners to develop and bring these mast cell–focused therapies to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Jasper Therapeutics.
Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 10, 2025
